LRRC4C antibody (AA 551-640)
Quick Overview for LRRC4C antibody (AA 551-640) (ABIN1304865)
Target
See all LRRC4C AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 551-640
-
Specificity
- No off-targets reported for NGL-2 or NGL-3
-
Cross-Reactivity
- Human, Mouse, Rat
-
Characteristics
-
Description: Our Anti-NGL-1/LRRC4C mouse monoclonal primary antibody is produced in-house from hybridoma clone N49A/21. It detects human, mouse, and rat NGL-1/LRRC4C, and is purified by Protein A chromatography. It is great for use in IHC, ICC, IP, WB.
Manufacturer Comment: We produce our NGL-1/LRRC4C mouse monoclonal primary antibody from hybridoma clone N49A/21. It is great in IHC, ICC, IP, WB and is purified by Protein A chromatography.
-
Purification
- Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography.
-
Purity
- > 90% specific antibody
-
Immunogen
- Fusion protein amino acids 551-640 of human NGL-1 (accession number NP_065980) produced recombinantly in E. Coli
-
Isotype
- IgG1
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 10 mM Tris, 50 mM Sodium Chloride, 0.065 % Sodium Azide pH 7.4
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
-
Expiry Date
- 24 months
-
-
- LRRC4C (Leucine Rich Repeat Containing 4C (LRRC4C))
-
Alternative Name
- LRRC4C
-
Background
-
Synonyms: Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1)
Target Description: Leucine Rich Repeat Containing 4C is encoded by the gene LRRC4C. LRRC4C may promote neurite outgrowth of developing thalamic neurons. LRRC4C is expressed in the brain. Diseases associated with LRRC4C include Extragonadal Seminoma and Chief Cell Adenoma.
Gene Name Alternatives: LRRC4C KIAA1580 NGL1 UNQ292/PRO331
-
Molecular Weight
- 100 kDa
-
UniProt
- Q9HCJ2
-
Pathways
- Synaptic Membrane
Target
-